Abstract
In our first jejunoileal bypass (JIB) of 1954 (described in the preface) we were uncertain what the optimal lengths of the functioning bowel should be. We erred on the conservative side, making them longer than lengths which subsequently proved to be effective. Ninety cm of jejunum were anastomosed to 45 cm of ileum, and the distal end of the bypassed small intestine was anastomosed to the transverse colon.1,2 In 1971, the patient’s JIB was revised by shortening the functioning jejunum to 40 cm, and the ileum to 15 cm. Her weight then decreased from 240 lb to 171 lb, and leveled off in a few years at 190 lb. Although she was happy about her weight loss and increased mobility, she required intermittent supplementation with magnesium, calcium, and potassium. In addition, during the last year of her life she developed angina pectoris and electrocardiographic evidence of coronary insufficiency despite a low serum cholesterol (60 to 120 mg%) and a normal serum triglyceride. She died in 1981 of a myocardial infarction at the age of 61 years.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kremen AJ, Linner JH, Nelson CH: An experi-mental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 140: 439–1954.
Linner JH: A summary of 24 years experience with surgery for morbid obesity. Am J Clin Nutr 33: 504, 1980.
Payne JH, DeWind LT, Commons RR: Metabolic observations in patients with jejunocolic shunts. Am J Surg 106: 273, 1963.
Payne JH, DeWind L, Schwab CE, Kern WH: Surgical treatment of morbid obesity, 16 years of experience. Arch Surg 106: 432, 1973.
Scott HW Jr, Dean R, Shull HJ, Abram HS, Webb W, Younger RK, Brill AB: New considerations in use of jejunoileal bypass in patients with morbid obesity. Ann Surg 177: 723, 1973.
Scott HW Jr: Surgical modifications of jejunoileal bypass. In: Surgical Management of Obesity. New York, Academic Press, 1980, pp 17–27.
Buchwald H, Vareo RL, Moore RB, Schwartz MZ: Intestinal bypass procedures. Curr Prob Surg 12:1–51, Ap. 1975.
Baddeley RM: The management of gross refractory obesity by jejuno-ileal bypass. Br J Surg 66: 525, 1979.
Salmon PA: The results of small intestine bypass operations for the treatment of obesity. Surg Gynecol Obstet 132: 965, 1971.
Benfield JR, Greeway FL, Bray GA, Barry RE, Lechago J, Mena I, Schedewie H: Experience with jejunoileal bypass for obesity. Surg Gynecol Obstet 143: 401, 1976.
Hallberg D, Backman L, Espmark S: Surgical treatment of obesity. Prog Surg 14: 46–83, 1975.
Nachlas MM, Crawford DT, Pearl JM: Current status of jejunoileal bypass in the treatment of morbid obesity. Surg Gynecol Obstet 150: 250, 1980.
Wills CE Jr: Small bowel bypass for obesity. A discussion of four different procedures. J Med Assoc Ga 61: 322, 1972.
Starkloff GB, Donovan JF, Ramach R, Wolfe BM: Metabolic intestinal surgery: its complications and management. Arch Surg 110: 652, 1975.
Bray GA, Barry RE, Benfield JR, CastelnuovoTedesco P, Rodin J: Intestinal bypass surgery for obesity decreases food intake and taste preferences. Am J Clin Nutr 29: 779, 1976.
Fairclough PD, Kumar PJ, Clark ML, Aggis A, Rimmer D, Pilkington TRE, Gazet JC: Intestinal adaptation. In: Surgical Management of Obesity. New York, Academic Press, 1980, pp 103–114.
Mason EE: Development of gastric bypass and gastroplasty. In: Surgical Management of Obesity. New York, Academic Press, 1980, p 29.
Van Itallie TB, Kral JG: The dilemma of morbid obesity. JAMA 246: 999, 1981.
dayman CB, O’Reilly DJ: Jejunoileal bypass: Pass it by. JAMA 246: 988, 1981.
Andersen T, Juhl E, Quaade F: Fatal outcome after jejunoileal bypass for obesity. Am J Surg 142: 619, 1981.
Maxwell JD: Intestinal bypass and the liver. In: Surgical Management of Obesity. New York, Academic Press, 1980, pp 235–255.
Iber FL, Cooper M: Jejunoileal bypass for the treatment of massive obesity. Prevalence, morbidity, and shortand long-term consequences. Am J Clin Nutr 30: 4, 1977.
Marubbio HT, Rucker RD Jr, Schneider PP, Horstmann JP, Vareo RL, Buchwald H: The liver in morbid obesity and following bypass surgery for obesity. Surg Clin North Am 59: 1079–1093, 1979.
Hocking MP, Duerson MC, Alexander RW, Woodward ER: Late hepatic histopathology after jejunoileal bypass for morbid obesity. Relation of abnormalities to clinical course. Am J Surg 141: 159, 1981.
Peters RL, Gay T, Reynolds TB: Post-jejunoilealbypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Coll Phys 63: 318, 1975.
Brown RG, O’Leary JP, Woodward ER: Hepatic effects of jejunoileal bypass for morbid obesity. Am J Surg 127: 53, 1974.
Yost RL, Duerson MC, Russell WL, O’Leary JP: Doxycycline in the prevention of hepatic dysfunction. An evaluation of its use following JIB in humans. Arch Surg 114: 931, 1979.
Baker AL, Elson CO, Jaspan J, Boyer JL: Liver failure with steatonecrosis after jejunoileal bypass. Recovery with parenteral nutrition and reanastomosis. Arch Intern Med 139: 289, 1979.
Heimburger SL, Steiger E, LoGerfo P, Biehl AG, Williams MJ: Reversal of severe fatty hepatic infiltration after intestinal bypass for morbid obesity by calorie-free amino acid infusion. Am J Surg 129: 229, 1975.
Mason EE: Surgical treatment of morbid obesity. Major Probl Clin Surg. Philadelphia, Saunders, 1981, p 422.
Peters RL: Hepatic morphologic changes after jejunoileal bypass. In: Progress in Liver Diseases, Vol. 6. New York, Grune & Stratton, 1979, pp 581–594.
Drenick RJ, Fisler D, Johnson D: Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole, irrespective of protein calorie malnutrition. Gastroenterology 82: 535, 1981.
Thaler H: Relation of steatosis to cirrhosis. Clin Gastroenterol 4: 273, 1975.
Salmon PA: Fatty metamorphosis in patients with jejunoileal bypass. Surg Gynecol Obstet 141: 75, 1975.
Drenick EJ, Stanley TM, Border WA, Zawada ET, Dornfield LP, Upham T, Llach F: Renal damage with intestinal bypass. Ann Intern Med 89: 594, 1978.
Wieland RG, Geraci K, Jones JC, Elkhaivi S: Intestinal bypass for obesity. JAMA 247: 2098, 1982.
O’Reilly DJ, Clayman CB: Reply. Intestinal bypass for obesity. JAMA 247: 2098, 1982.
Mezey E, Imbembo AL: Hepatic collagen proline hydroxylase activity in hepatic disease following jejunoileal bypass for morbid obesity. Surgery 83: 345, 1978.
Buchanan RF, Willkens RF: Arthritis after jejunoileostomy. Arthritis Rheum 15: 644, 1972.
Shagrin JW, Frame B, Duncan H: Polyarthritis in obese patients with intestinal bypass. Ann Intern Med 75: 377, 1971.
Kennedy C: Inflammatory skin and joint disease after intestinal bypass. In: Surgical Management Of Obesity. New York, Academic Press, 1980, pp 273 - 286.
Drenick EJ, Ament ME, Finegold SM, Corrode P, Passaro E: Bypass enteropathy. Intestinal and systemic manifestations following small bowel bypass. JAMA 236: 269, 1976.
Wands JR, LaMont JT, Mann E, Isselbacher KJ: Arthritis associated with intestinal bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med 294: 122, 1976.
Troy JL: The bowel bypass syndrome. Am J Dermatol Pathol 3: 361, 1981.
Kennedy C: Inflammatory skin and joint disease after intestinal bypass. In: Surgical Management Of Obesity. New York, Academic Press, 1980, p 276.
Leung FW, Drenick EJ, Stanley TM: Intestinal bypass complications involving the excluded small bowel segment. Am J Gastroenterol 77: 67, 1982.
Passaro E, Drenick EJ, Wilson SE: Bypass enteritis: a new complication of jejunoileal bypass for obesity. Am J Surg 131: 169, 1976.
Martyak SN: Pneumotosis intestinalis. A complication of jejunoileal bypass. JAMA 235: 1038, 1976.
Thayer WR, Kirsner JB: Enteric and extra-enteric complications of intestinal bypass and inflammatory bowel disease. Are there some clues? Gastroenterology 78: 1097, 1980.
Joffe SN: Surgical management of morbid obesity. Progress report. Gut 22: 242, 1981.
Phillips RB: Small intestinal bypass for the treatment of morbid obesity (collective reviews). Surg Gynecol Obstet 146: 455, 1978.
Baddeley RM: Indications for reversal of jejunoileal bypass. In: Surgical Management Of Obesity. New York, Academic Press, 1980, pp 293–303.
Ayub A, Faloon WW, Heinig RE: Encephalopathy following jejunoileostomy. JAMA 246: 970, 1981.
Carr DB, Shih VE, Richter JM, Martin JB: Encephalopathy following jejunoileostomy. JAMA 247: 1127, 1982.
Mason EE: Surgical treatment of morbid obesity. Major Probl Clin Surg. Philadelphia, Saunders, 1981, pp 94–95.
Mosekilde L, Meisen F, Hessov I, Christensen MS, Lund BJ, Sorensen OH: Low serum levels of 1,25dehydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut 21: 624, 1980.
Hey H, Lund B, Sorensen OH, Lind BJ, Christenson MS: Impairment of vitamin D and bone metabolism in patients with bypass operation for obesity. Acta Med Scand (Suppl) 624: 73, 1979.
Teitelbaum SL, Halverson JD, Bates M, Wise L, Haddad JG: Abnormalities of circulating 25-OHvitamin D after jejunoileal bypass for obesity. Ann Intern Med 86: 289, 1977.
Compston JE, Horton LWL, Laker MF, Merrett AL, Woodhead JS, Gazet JC, Pilkington TRE: Treatment of bone disease after jejunoileal bypass for obesity with oral L-hydroxy-vitamin D3. Gut 21: 669, 1980.
MacLean LD: Host resistance in surgical patients. Trauma 19: 297, 1979.
Pickleman JR, Evans LS, Kane JM, Freeark RJ: Tuberculosis after jejunoileal bypass for obesity. JAMA 234: 744, 1975.
Yu VL: Onset of tuberculosis after intestinal bypass surgery for obesity. Guidelines for evaluation, drug prophylaxis, and treatment. Arch Surg 112: 1235, 1977.
Tustin AW, Kaiser AB, Bradsher RW, Herrington JL: Unusual fungal infections following jejunoileal bypass surgery. Arch Intern Med 140: 643, 1980.
Hallberg D, Holmgren U: Bilio-intestinal shunt for treatment of obesity. Acta Chir Scand 145: 405, 1979.
Hallberg DA: Survey of surgical techniques for treatment of obesity and a remark on the biliointestinal bypass method. Am J Clin Nutr (Suppl) 33: 499, 1980.
Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V: Biliopancreatic bypass for obesity. II, Initial experience in man. Br J Surg 66: 618, 1979.
Holian DK: Biliopancreatic bypass for morbid obesity. Contemp Surg 21: 55, 1982.
References to Appendix
Anderson T, Juki E, Quaade F: Fatal outcome after jejunoileal bypass for obesity. Am J Surg 142: 619–621, 1981.
Griffen WO, Hostetter JM, Bell RM, Birins BA, Bannon C: Experiences with conversion of jejunoileal bypass to gastric bypass: its use for maintenance of weight loss. Arch Surg 116: 320–324, 1981.
Halverson JD, Gentry K, Wise L, Ballinger WF: Reanastomosis after jejunoileal bypass. Surgery 84: 241–249, 1978.
Dickstein SS, Frame B: Urinary tract calculi after intestinal shunt operations for treatment of obesity. Surg Gynecol Obstet 136: 257–260, 1973.
Gourlay RH, Reynolds C: Complications of surgery for morbid obesity. Am J Surg 136: 54–57, 1978.
Modigliani R, Labayle D, Aymes C, Denvil R: Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroenterology 13: 187–192, 1978.
Fikri E, Casella RR: Hyperoxaluria and urinary tract calculi after jejunoileal bypass. Am J Surg 129: 334–336, 1975.
Starkloff GB, Wolfe BM, Ramach KR: Management of complications following intestinal bypass for morbid obesity. Missouri Med 71: 119–121, 1974.
Gregory JG, Starkloff ZG, Miyai K, Schoenberg HW: Urologie complications of ileal bypass operation for morbid obesity. J Urol 113: 521–524, 1975.
Hodgkinson A: Oxalate metabolism in animals and man. In: Oxalic Acid in Biology and Medicine. New York, Academic Press, 1977, p 159.
Ney DM, Hoffman AF, Fischer C, Stubblefield N: The Low Oxalate Diet Book for Prevention of Oxalate Kidney Stones. San Diego, California, University of California, 1981.
Admirand WH, Earnest DL, Williams HE: Hyperoxaluria and bowel disease. Trans Assoc Am Physicians 84: 307–312, 1971.
Dowling RH, Rose GA, Sutor DJ: Hyperoxaluria and renal calculi in ileal disease. Lancet 1: 1103–1106, 1971.
Hoffman AF, Thomas PI, Smith LH, McCall JT: Pathogenesis of secondary hyperoxaluria in patients with ileal resection and diarrhea. Gastroenterology 58A: 960, 1970.
Chadwick VS, Modha K, Dowling RH: Pathogenesis of secondary hyperoxaluria in patients with ileal resection. Gut 13A: 840, 1972.
Chadwick VS, Elias E, Modha K, Dowling RH: Pathogenesis and treatment of secondary hyperoxaluria in patients with ileal resection. Q J Med 42A: 826, 1973.
Gershoff SN, Faragalla FF, Nelson DA, Andrus SB: Vitamin B6 deficiency and oxalate nephrocalcinosis in the cat. Am J Med 27: 72–80, 1959.
Ludwig GD: Renal calculi associated with hyperoxaluria. Ann NY Acad Sei 104: 621–637, 1963.
Smith CL, Linner JH: Dissolution of calcium oxalate renal stones in patients with jejunoileal bypass and after reanastomosis. Urology 19: 21–23, 1982.
Williams HE: Oxalic acid and the hyperoxaluria syndromes. Kidney Int 13: 410–417, 1978.
Bachman L, Eliasson B, Larsson L: Studies on endogenous oxalate production after jejunoileostomy for treatment of obesity. In Brockis JG, Finlayson B (eds): Urinary Calculus: International Urinary Stone Conference. Little Town, Mass., PSG, 1979, p 169.
Zarembski PM, Hodgkinson A: Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta 25: 1–10, 1969.
Binder HJ: Intestinal oxalate absorption. Gas-troenterology 67: 441–446, 1974.
Earnest DL, Williams HE, Admirand WH: Excessive absorption of oxalate contributes to hyperoxaluria in patients with ileal disease. Gastroenterology 64A: 723, 1973.
Stauffer JQ, Humphreys MH, Weir GJ: Acquired hyperoxaluria with regional enteritis after ileal resection: role of dietary oxalate. Ann Intern Med 79: 383–391, 1973.
Chadwick VS, Modha K, Dowling RH: Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 289: 172–176, 1973.
Anderson H, Jagenburg R: Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy. Gut 15: 360–366, 1974.
Earnest DL, Johnson G, Williams HE, Admirand WH: Hyperoxaluria in patients with ileal resection: An abnormality in dietary oxalate absorption. Gastroenterology 66: 1114–1122, 1974.
McDonald GB, Earnest DL, Admirand WH: Hyperoxaluria correlates with steatorrhea in patients with celiac sprue. Gastroenterology 68A: 949, 1975.
Stauffer JQ, Stewart JR, Bertand F: Acquired hyperoxaluria: relationship to dietary calcium content and severity of steatorrhea. Gastroenterology 66A: 783, 1974.
Earnest DL, Williams HE, Admirand WH: A physiochemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Physicians 88: 224–232, 1975.
Chadwick VS: Hyperoxaluria and ileal dysfunction. N Engl J Med 290: 108, 1974.
Smith LH, Fromm H, Hoffman AF: Acquired hyperoxaluria, nephrolithiasis, and intestinal disease: description of a syndrome. N Engl J Med 286: 1371–1375, 1972.
Dobbins JW, Binder HJ: Effects of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70: 1096–1100, 1976.
Smith CL, Linner JH, Wathen RL: Urinary oxalate excretion following ileo-jejunal bypass surgery for morbid obesity. Clin Res 24: 370A, 1976.
Pak CYC, Sakhu K, Crowther C, Brinkley L: Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med 93: 36–39, 1980.
Stockholm KH, Hoilund-Carlson PF, BrochnerMortenson J: Glomerular-filtration rate after jejunoilel bypass for obesity. Int J Obes 5: 77–80, 1981.
Rudman D, Dedonis JL, Fountain MT, Chandler JB, Gerron GG, Fleming GA, Kutner MH: Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med 303: 657–661, 1980.
Cohn JJ, Barac-Nieto M: Renal metabolism of substrates in relation to renal function. IV. Renal metabolism of citrate. In Orlaflf J, Berliner RW (eds)r Handbook of Physiology. Section 8: Renal Physiology. Washington, D.C., American Physiological Society, 1973, pp 948–961.
Farmer RG, Mir-Madjlessi SH, Kiser WS: Uri-nary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease. Cleve Clin Q 41: 109–117, 1974.
Fleisch H: Inhibitors and promoters of stone formation. Kidney Int 13: 361–371, 1978.
Hammarstein G: On calcium oxalate and its solubility in the presence of inorganic salts with special reference to the occurrence of oxaluria. CR Travaux Lab Carlsberg 17: 1–83, 1929.
Hallson PC, Rose GA, Sulaiman S: Magnesium reduces calcium oxalate crystal formation in human whole urine. Clin Sci 62: 17–19, 1982.
Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B: Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124: 770–774, 1980.
Crisp AH, Kalucy RS, Pilington TRE, Gazet JC: Some psychosocial consequences of ileojejunal bypass surgery. Am J Clin Nutr 30: 109–119, 1977.
Clayman RV, Williams RD: Oxalate urolithiasis following jejunoileal bypass: mechanism and management. Surg Clin North Am 59: 1071–1077, 1979.
Gelbart DR, Brewer LL, Fajardo LF, Weinstein AB: Oxalosis and chronic renal failure after intestinal bypass. Arch Intern Med 137: 239–243, 1977.
O’Leary JP, Thomas WC, Woodward ER: Urinary tract stone after small bowel bypass for morbid obesity. Am J Surg 127: 142–147, 1974.
Pyrah LN: Uric acid calculi. In: Renal Calculus. New York, Springer-Verlag, 1979, pp 320–338.
Halverson JD: Obesity surgery in perspective. Surgery 87: 119–127, 1980.
Starkloflf GG, Donovan JF, Ramaeh R, Wolfe BM: Metabolic intestinal surgery: its complications and management. Arch Sug 110: 652–657, 1975.
Earnest DL: Perspectives on incidence, etiology, and treatment of enteric hyperoxaluria. Am J Clin Nutr 30: 72–75, 1977.
Cooke N, Teitlbaum S, Avioli LV: Antacid-in-duced osteomalacia and nephrolithiasis. Arch Intern Med 138: 1007–1009, 1978.
Insogna KL, Bordley DR, Caro JF, Lockwood DH: Osteomalacia and weakness from excess antacid ingestion. JAMA 244: 2544–2546, 1980.
Franck WA, Hoflfman GS, Davis JS, Alpern HD, Olson JE: Osteomalacia and weakness complicating jejunoileal bypass. J Rheumatol 6: 51–56, 1979.
Knochel JP: Hypophosphatemia. Clin Nephrol 7: 131–137, 1977.
Coburn JW, Massry SG: Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest 49: 1073–1087, 1970.
Gregory JG: Hyperoxaluria and stone disease in the gastrointestinal bypass patient. Urol Clin North Am 8: 331–351, 1981.
Dean RH, Scott W, Shull HJ, Gluck FW: Morbid obesity: problems associated with operative management. Am J Clin Nutr 30: 90–97, 1977.
Bray GA, Benfield JR: Intestinal bypass for obesity: a summary and perspective. Am J Clin Nutr 30: 121–127, 1977.
Hey H, Skaarup P, Soiling K, Christensen MS, Lund B, Sorensen OH, Lund B: Tubular proteinuria following jejunoileal bypass surgery. Int J Obes 5: 155–161, 1981.
Jensen JB, Nielsen IL, Hensen HE, Nielsen B: Renal tubular acidosis as a complication of jejunoileostomy in obese patients. Ugeskr Lalger 138: 2742–2745, 1977.
Payne JH, DeWind L, Schwab CE, Kern WH: Surgical treatment of morbid obesity: 16 years of experience. Arch Surg 106: 432–436, 1973.
Vainder M, Kelly J: Renal tubular dysfunction secondary to jejunoileal bypass. JAMA 235: 1257 1258, 1976.
Halverson JD, Wise L, Wazna MF, Ballinger WF: Jejunoileal bypass for morbid obesity: A critical appraisal. Am J Med 64: 461–475, 1978.
Sweet RM, Smith CL, Berkseth RB, Crosson JT, Wathen RL: Jejunoileal bypass surgery and granulomatous disease of the kidney and liver. Arch Intern Med 138: 626–627, 1978.
Drenick EJ, Stanley TM, Border WA, Zawada ET, Dornfield LP, Upham T, Llach F: Renal damage with intestinal bypass. Ann Intern Med 89: 594–599, 1978.
Gamble CN, Kinichi A, Dynn TA, Christensen D: Immune complex glomerulonephritis and dermal vasculitis following intestinal bypass for morbid obesity. Am J Clin Pathol 77: 347–352, 1982.
Utsinger PD: Systemic immune complex disease following intestinal bypass surgery. J Am Acad Dermatol 2: 488–495, 1980.
Payne JH, DeWind LT, Commons RR: Metabolic observations in patients with jejunocolic shunts. Am J Surg 106: 273–289, 1963.
Cryer PE, Garber AJ, Hoffstein P, Luca B, Wise L: Renal failure after small intestinal bypass for obesity. Arch Intern Med 135: 1610–1612, 1975.
Das S, Joseph B, Dick AL: Renal failure owing to oxalate nephrosis after jejunoileal bypass. J Urol 121: 506–509, 1979.
DeWind LT, Payne JH: Intestinal bypass surgery for morbid obesity: long-term results. JAMA 236: 2298–2301, 1976.
Ehlers SM, Posalaky Z, Strate RG, Quattlebaum FW: Acute reversible renal failure following jejunoileal bypass for morbid obesity: a clinical and pathological (EM) study of a case. Surgery 82: 628633, 1977.
Scott, HW, Dean RH, Shull HJ, Gluck F: Results of jejunoileal bypass in 200 patients with morbid obesity. Surg Gynecol Obstet 145: 661–673, 1977.
Rights and permissions
Copyright information
© 1984 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Linner, J.H. (1984). Malabsorption Techniques. In: Surgery for Morbid Obesity. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8245-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8245-4_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8247-8
Online ISBN: 978-1-4613-8245-4
eBook Packages: Springer Book Archive